Presentation Information
[S04-1]Development of cancer-specific therapeutic agents: Perspectives from BNCT and photoimmunotherapy
○Naoya Kondo1,2 (1. NIR-PIT Res. Inst., Kansai Med. Univ., 2. Grad. Sch. Pharm. Sci., Osaka Med. Pharm. Univ.)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.